Biofarma Group
Biofarma Group is the new Italian and European market leader in developing, producing, and packaging food supplements, medical devices, probiotic-based drugs, and cosmetics exclusively for third parties. With a turnover of around 300 million euros expected in 2022 and 914 employees, Biofarma Group is already a focal point in the Health-Care sector in the Italian and European markets
Trending Articles
Related Content
Ingredients
Nutraceutical Business Review in conversation with International Health Science
In this exclusive video interview, NBR talks to Professor Francesco de Seta from the University of Trieste. The obstetrics and gynaecology expert discusses UTIs and the varying routes that can be taken to address and prevent, both natural and pharmaceutical
Finance
Biofarma Group reinforces its international presence by acquiring IHS
Giellepi’s finished product division has been renamed International Health Science (IHS) and Biofarma plans to compete at international level with scientifically supported and ready-to-market products available for out-licensing